Markets:

Overview

News

Currencies

International

Treasuries

ResMed Inc. Common Stock (NY:RMD)

256.26 -0.80 (-0.31%)

Official Closing Price Updated: 7:00 PM EST, Feb 27, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ResMed Inc. Common Stock

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

April 30, 2021

Gainers Motus GI Hldgs (NASDAQ:MOTS) stock increased by 46.78% to $1.6 during Friday's pre-market session. The market value of their outstanding shares is at $74.7...

Via Benzinga

ResMed (RMD) Q3 2021 Earnings Call Transcript ↗

April 29, 2021

RMD earnings call for the period ending March 31, 2021.

Via The Motley Fool

Topics Earnings

Earnings Scheduled For April 29, 2021 ↗

April 29, 2021

Companies Reporting Before The Bell • OSI Systems (NASDAQ:OSIS) is estimated to report quarterly earnings at $1.33 per share on revenue of $290.51 million. •...

Via Benzinga

3 Top Value Stocks in Healthcare to Buy Right Now ↗

April 21, 2021

Well-known guidance from Warren Buffett can help us identify opportunities in an expensive market.

Via The Motley Fool

2 Companies Whose Products, and Profits, Could Help You Sleep Better at Night ↗

April 14, 2021

With big growth trending for CPAP machines and related products, the two biggest names in sleep apnea are expected to prosper this year.

Via The Motley Fool

The Daily Biotech Pulse: Clinical Setback For Adverum, Galera Posts Data Readout, Moderna To Invest In Vaccine Manufacturing, Decision Day For Ardelyx ↗

April 29, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 28) Axonics, Inc. (NASDAQ:...

Via Benzinga

Investing in Sleep Apnea Companies ↗

April 09, 2021

Three stocks to have on your radar in the healthcare space.

Via The Motley Fool

The Week Ahead In Biotech (April 25-May 1): FDA Decisions For Sol-Gel, Protalix Bio, Ardelyx ↗

April 24, 2021

Biopharma stocks came back from the weakness seen in the first two sessions to close the week ended April 23 higher. Johnson & Johnson (NYSE: JNJ) and Roche Holding AG (OTC:...

Via Benzinga

< Previous 1 2

...

12 13 14 15 16 17 18 19 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.